Computer-Aided Detection for Colorectal Cancer
(COLOWISE Trial)
Trial Summary
What is the purpose of this trial?
This is a prospective, multicenter, randomized study to evaluate the clinical performance of a novel CADe device, WISE VISION® Endoscopy System, in patients undergoing high-definition white light (HDWL) colonoscopy for screening or surveillance of colorectal Cancer (CRC). Eligible subjects who meet the study inclusion/exclusion criteria will be randomized in a 1:1 ratio to undergo colonoscopy : * Experimental: CADe colonoscopy procedure with WISE VISION® Endoscopy (CADe Group) * Control: Standard Colonoscopy without CADe (Standard Colonoscopy Group)
Research Team
Hitoshi Ikeda
Principal Investigator
NEC Corporation
Eligibility Criteria
This trial is for individuals going to the endoscopy unit for colon cancer screening or surveillance. Participants must sign an informed consent form, indicating they understand and agree to the study's procedures.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- WISE VISION® Endoscopy System (Computer-Aided Detection)
Find a Clinic Near You
Who Is Running the Clinical Trial?
NEC Corporation
Lead Sponsor
Meditrial USA Inc.
Collaborator
Meditrial USA Inc.
Industry Sponsor
Meditrial Europe Ltd.
Industry Sponsor